对前列腺癌患者骨质疏松性脊椎骨折相关因素的分析
Shunfa Huang1, Lilan Wu1, Shuting Lin2
1Department of Radiology, Zhongshan Hospital (Xiamen), Fudan University, No.668 Jinhu Road, Huli District, Xiamen, 361015, China.
Discover oncology
|February 12, 2024
概括
前列腺癌患者经历了治疗后骨质疏松性脊椎骨折的显著增加,特别是基剥夺疗法 (ADT). 年龄被确定为这些骨折的主要危险因素.
科学领域:
- 整形外科 整形外科 整形外科
- 在瘤学瘤学.
- 放射学 放射学是一门学科.
背景情况:
- 前列腺癌是男性普遍存在的恶性瘤.
- 骨质疏松性脊椎骨折对健康构成重大风险.
- 前列腺癌治疗对骨健康的影响越来越令人担忧.
研究的目的:
- 研究前列腺癌患者治疗前后骨质疏松性脊椎骨折的患病率.
- 在这个患者群体中确定与这些骨折相关的因果因素.
主要方法:
- 分析了100名前列腺癌患者和100名对照组的队列.
- 脊椎骨折 (T4-L1) 用Genant的半定量方法进行评估.
- 后勤回归模型确定了影响骨折率的因素.
主要成果:
- 在前列腺癌患者治疗后,脊椎骨折的患病率从16%增加到31%.
- 与对照组 (29%) 相比,治疗前列腺癌患者 (31%) 的骨折率更高.
- 年龄,前列腺特异性抗原 (PSA) 水平和治疗参数,特别是雌激素剥夺疗法 (ADT),是重要的因素.
结论:
- 前列腺癌患者的骨质疏松性脊椎骨折是多因素的.
- 抗雄激素剥夺疗法 (ADT) 显著提高了脊椎骨折的风险.
更多相关视频
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.1K
06:59Author Spotlight: An Economic and Efficient Method for Quantitative Evaluation of Bone Microarchitecture in a Murine Osteoporosis Model
Published on: September 8, 2023
2.4K
相关概念视频
Bone Disorders
3.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.5K
Cancer Survival Analysis
346
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
346
Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K
Role of Vitamins in Maintaining Bone Health
3.3K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
3.3K
